WORK to Save Lives Act

Bill: 118-s-2948
Sponsor: full_name: Sen. Merkley, Jeff [D-OR]
Introduced: 2023-09-27
Policy area: Labor and Employment
Latest action: action_date: 2023-09-27
text: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Summaries:
action_date: 2023-09-27
action_desc: Introduced in Senate
text: <p><strong>Workplace Overdose Reversal Kits to Save Lives Act or the WORK to Save Lives Act</strong></p><p>This bill directs the Occupational Safety and Health Administration (OSHA) to take actions to make opioid overdose reversal medications available in workplaces.</p><p>Specifically, OSHA must issue regulations that require federal agencies to acquire and maintain opioid overdose reversal medications and annually train employees on the use of the medications. OSHA must also issue nonmandatory guidance to private employers on the same topics.&nbsp;</p>

tv_txt: II 118th CONGRESS 1st Session S. 2948 IN THE SENATE OF THE UNITED STATES September 27 (legislative day, September 22), 2023 Mr. Merkley introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions A BILL To require the Secretary of Labor to issue guidance and regulations regarding opioid overdose reversal medication and employee training.

1. Short title This Act may be cited as the Workplace Overdose Reversal Kits to Save Lives Act or the WORK to Save Lives Act . 2. Non-mandatory guidance for employers concerning opioid overdose reversal medication (a) In general Not later than 270 days after the date of enactment of this Act, the Secretary of Labor, acting through the Occupational Safety and Health Administration, shall issue nonmandatory guidance to employers on— (1) acquiring and maintaining opioid overdose reversal medication; and (2) training employees on an annual basis on the usage of such medication. (b) Employer defined In this section, the term employer has the meaning given such term in section 3 of the Occupational Safety and Health Act of 1970 ( 29 U.S.C. 652 ), except that such term does not include the United States Postal Service. 3. Mandatory regulations for Federal agencies concerning opioid overdose reversal medication (a) In general Not later than 270 days after the date of enactment of this Act, the Secretary of Labor, acting through the Occupational Safety and Health Administration, shall issue regulations to require each Federal agency to— (1) acquire and maintain opioid overdose reversal medication; and (2) train employees on an annual basis on the usage of such medication. (b) Federal agency defined In this section, the term Federal agency means any agency or instrumentality of the Federal Government, including the Veterans Health Administration, notwithstanding section 7425(b) of title 38, United States Code.